Skip to content
Company Analysis

Heart Test Laboratories, Inc. W HSCSW

A comprehensive view of key metrics, scores, and financial health for Heart Test Laboratories, Inc. W

Overview of HeartSciences Inc.

HSCSW NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics
HeartSciences Inc. (HSCSW), in the Medical Devices industry, last closed at $0.13, about 0.0% overvalued vs fair value, ranked 853/1145 in sector.
Metrics Rev Growth -0.7% ROE -4239.9% Gross Margin 59.1%
USD 0.13
154.90%
(Delayed)
• Vol 90d: 242.2%
52-Week Range
Enterprise Value
-
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Good
Valuation
Excellent
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Good
Valuation
Excellent
Completeness: 76%
Confidence: 77%
Updated: Oct 24
Top Beats
No strong beats yet

Quick Facts

Website https://heartsciences.com
HQ Southlake, TX
Employees 15
Fiscal year Apr 30

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$4.3K
-0.7%%
Gross Profit
$2.6K
3.3%%
Operating Income (GAAP)
-$8.4M
-0.7%%
EBITDA
-$8.3M
-1.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
59.1%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Heart Test Laboratories, Inc. W's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
18
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Durable Revenue Growth Revenue growth trend is strong (score 0.93). Durable top-line expansion confirms the razor-and-blade flywheel is working.

Key risks

  • Weak FCF Generation FCF margin quality lags peers (score 0.01). Below-peer FCF conversion is a MedTech quality warning.
  • Weak Capital Return Profile Capital return quality is below peers (score 0.07). Low ROIC raises questions about M&A discipline and pipeline ROI.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
40
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 77% Coverage
Trade-Off Triangle Visualization A ternary plot showing HSCSW's balance between Growth (46.4%), Profitability (21.3%), and Safety (32.3%). Growth 46% Safety 32% Profitability 21%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

31th percentile vs peers
31
Key Signals
Rev Growth YoY -0.7% 31p Asset Growth YoY 24.6% 84p Revenue CAGR 3Y -5.7% 18p
Strengths

No notable strengths identified for this axis.

Risks

No significant risks identified for this axis.

Profitability

14th percentile vs peers
14
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

21th percentile vs peers
22
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Heart Test Laboratories, Inc. W.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000